Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Extended dosing of dupilumab in patients with AD has similar efficacy as standard dosing, with no significant affect seen on ocular adverse events.
Sydney, Australia Highlights Robust CV5 lithium-only Feasibility Study ("FS") completed on the Shaakichiuwaanaan Project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback